基于血清N-糖组学分析的慢性乙型肝炎患者肝细胞癌早期筛查、诊断与复发监测:一项队列研究
本研究纳入397例慢性乙型肝炎相关肝硬化及肝细胞癌患者进行N-糖组学分析和临床数据收集,建立了基于机器学习的肝细胞癌糖组学随机森林模型和 support vector machine 模型用于早期筛查和诊断,验证集AUC分别为0.967(95%CI:0.930-1.000)和0.908(0.840-0.976),优于AFP(0.687[0.575-0.765])和PIVKA-II(0.665[0.507-0.823])。同时开发了基于N-糖链的预后模型prog-G用于监测根治性治疗后肝细胞癌复发,该模型可在影像学发现前识别全部12例复发病例,优于AFP(7例)和PIVKA-II(9例)。
要点
- 基于N-糖组学的随机森林模型验证集AUC为0.967,优于AFP和PIVKA-II。
- prog-G模型可在影像学发现前识别全部12例复发,优于AFP(7例)和PIVKA-II(9例)。
核心结论
- N-糖组学模型可有效预测肝细胞癌的发生和复发,提高临床决策效率并促进肝细胞癌的精准治疗。
研究设计与样本
- 本研究为队列研究,共纳入397例慢性乙型肝炎相关肝硬化及肝细胞癌患者进行临床管理,对所有参与者进行N-糖组学分析和临床数据收集。
主要发现
- 验证集中肝细胞癌糖组学随机森林模型AUC为0.967(95%CI:0.930-1.000),肝细胞癌糖组学 support vector machine 模型AUC为0.908(0.840-0.976),均优于AFP(0.687[0.575-0.765])和PIVKA-II(0.665[0.507-0.823])。
- 糖组学模型在亚组分析和外部验证中也显示出优势,校准和决策曲线分析显示良好的预测性能。
- 基于N-糖链的预后模型prog-G在随访期间与患者临床状况相关,可在影像学发现前识别全部复发病例(n=12),优于AFP(n=7)和PIVKA-II(n=9),并较影像学更早检测到复发病灶。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: HCC poses a significant global health burden, with HBV being the predominant etiology in China. However, current diagnostic markers lack the requisite sensitivity and specificity. This study aims to develop and validate serum N-glycomics-based models for the diagnosis and prognosis of HCC in patients with chronic hepatitis B-related cirrhosis. APPROACH AND RESULTS: This study enrolled a total of 397 patients with chronic hepatitis B-related cirrhosis and HCC for clinical management. N-glycomics profiling was conducted on all participants, and clinical data were collected. First, machine learning-based models, Hepatocellular Carcinoma Glycomics Random Forest model and Hepatocellular Carcinoma Glycomics Support Vector Machine model, were established for early screening and diagnosis of HCC using N-glycomics. The AUC values in the validation set were 0.967 (95% CI: 0.930-1.000) and 0.908 (0.840-0.976) for Hepatocellular Carcinoma Glycomics Random Forest model and Hepatocellular Carcinoma Glycomics Support Vector Machine model, respectively, outperforming AFP (0.687 [0.575-0.765]) and Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) (0.665 [0.507-0.823]). It also showed superiority in subgroup analysis and external validation. Calibration and decision curve analysis also showed good predictive performance. Additionally, we developed a prognostic model, the prog-G model, based on N-glycans to monitor recurrence in patients with HCC after curative treatment. During the follow-up period, it was observed that this model correlated with the clinical condition of the patients and could identify all recurrent HCC cases (n=12) prior to imaging findings, outperforming AFP (n=7) and PIVKA-II (n=9), while also detecting recurrent lesions earlier than imaging. CONCLUSIONS: N-glycomics models can effectively predict the occurrence and recurrence of HCC to improving the efficiency of clinical decision-making and promoting the precision treatment of HCC.
引用
- Su R, Tao X, Yan L, et al. Early screening, diagnosis and recurrence monitoring of hepatocellular carcinoma in patients with chronic hepatitis B based on serum N-glycomics analysis: A cohort study. Hepatology. 2025. PMID: 40117651. doi:10.1097/HEP.0000000000001316
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。